Description
Catalogue Number | IM136751 |
CAS No. | 106635-80-7 |
Chemical Name | Tafenoquine |
Synonyms | 1,4-Pentanediamine, N4-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]-8-quinolinyl]-; N4-[2,6-Dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]-8-quinolinyl]-1,4-pentanediamine; SB 252263AAB; WR 238605; |
Molecular Formula | C₂₄H₂₈F₃N₃O₃ |
Molecular Weight | 463.49 |
Appearance | Dark Orange to Very Dark Orange Solid |
Melting Point | 60 – 63°C |
Storage | 4°C |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Applications | Tafenoquine is a pharmaceutical developed for the treatment of Plasmodium vivax malaria. Tafenoquine is also being explored for pharmaceutical use for inhibition of Toxoplasma gondii growth. |
Category | Standards; Pharmaceutical/API Drug Impurities/Metabolites; Anti-virals/Anti-retrovirals; |
Note: All Products are stable to be shipped at room temperature, unless otherwise specified.